CTLA4 and rheumatoid arthritis: Although this study demonstrated the in vitro capability of CTLA4-Ig to promote the shift from an M1 to an M2 phenotype in RA-MDMs, future experiments on cultured synovial macrophages need to be considered in order to improve the relevance of these results and the potential therapeutical importance of CTLA4-Ig treatment in RA patients.